Helicobacter pylori surface and enzyme components

Helicobacter pylori surface and enzyme components represent a diverse array of molecular targets essential for the survival and pathogenicity of the bacterium within the acidic human gastric environment. A primary component is the enzyme urease, which facilitates colonization by neutralizing stomach acid through the production of ammonia (Kusters et al., 2006). Surface-localized proteins, including adhesins like BabA and SabA, enable the bacterium to anchor to the gastric mucosa, while the Type IV secretion system delivers virulence factors such as CagA directly into host cells (Amieva & Peek, 2016). Additionally, the secreted VacA toxin contributes to epithelial damage by inducing cell vacuolation and apoptosis. These components are the focus of standard triple and quadruple eradication therapies, where antibiotics target bacterial cell wall synthesis, protein translation, and DNA integrity (Malfertheiner et al., 2022). They also serve as critical diagnostic markers in clinical practice, utilized in urea breath tests and stool antigen assays to confirm infection (StatPearls, 2023). The increasing prevalence of antibiotic resistance against these targets, particularly in the case of clarithromycin, remains a significant challenge in clinical management. Research into vaccines targeting these surface components continues as a potential strategy for long-term prevention of H. pylori-associated diseases.

Other names

H. pylori antigensH. pylori virulence factorsH. pylori proteinsHelicobacter pylori targets

Inhibition of bacterial cell wall synthesis (Amoxicillin), inhibition of protein synthesis via 50S (Clarithromycin) or 30S (Tetracycline) ribosomal subunits, induction of DNA damage (Metronidazole), and inhibition of DNA gyrase (Levofloxacin) (Malfertheiner et al., 2022).